Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1872]

Choosing wisely for young women with breast cancer: Surgery

Dr Shalaka Joshi - Tata Memorial Hospital, Mumbai, India

Choosing wisely for young women with breast cancer: Surgery ( Dr Shalaka Joshi - Tata Memorial Hospital, Mumbai, India )

Choosing Wisely for young women with breast cancer: Radiotherapy

Dr Tabassum Wadasadawala - Tata Memorial Hospital, Mumbai, India

Choosing Wisely for young women with breast cancer: Radiotherapy ( Dr Tabassum Wadasadawala - Tata Memorial Hospital, Mumbai, India )

Choosing Wisely for young women with breast cancer: Medical therapy

Dr Shriniwas Kulkarni - Sahyadri Superspeciality Hospital,Pune, India

Choosing Wisely for young women with breast cancer: Medical therapy ( Dr Shriniwas Kulkarni - Sahyadri Superspeciality Hospital,Pune, India )

ESMO 2024: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada

ESMO 2024: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )

Durvalumab and oleclumab boost for SBRT plus chemo in ER+/HER2- breast cancer

Dr Alex De Caluwe - Institut Jules Bordet, Brussels, Belgium

Durvalumab and oleclumab boost for SBRT plus chemo in ER+/HER2- breast cancer ( Dr Alex De Caluwe - Institut Jules Bordet, Brussels, Belgium )

Radiation therapy for breast cancer can be safely shortened by changing...

Dr Sofia Rivera - Institut Gustave Roussy, Villejuif, France

Radiation therapy for breast cancer can be safely shortened by changing technique ( Dr Sofia Rivera - Institut Gustave Roussy, Villejuif, France )

No OS improvement over chemo from capivasertib plus paclitaxel in advanced TNBC

Dr Heather McArthur - UT Southwestern Medical Center, Dallas, USA

No OS improvement over chemo from capivasertib plus paclitaxel in advanced TNBC ( Dr Heather McArthur - UT Southwestern Medical Center, Dallas, USA )

Mutational-based treatment approach may significantly improve outcomes in...

Dr Andrea Botticelli - Sapienza Università di Roma, Rome, Italy

Mutational-based treatment approach may significantly improve outcomes in pretreated patients with metastatic solid tumours ( Dr Andrea Botticelli - Sapienza Università di Roma, Rome, Italy )

TNBC: Neoadjuvant pembrolizumab plus chemo followed by adjuvant pembrolizumab...

Prof Peter Schmid - Barts Cancer Institute, London, UK

TNBC: Neoadjuvant pembrolizumab plus chemo followed by adjuvant pembrolizumab shows improvement in OS compared to neoadjuvant chemo alone ( Prof Peter Schmid - Barts Cancer Institute, London, UK )

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2...

Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA

ERBB2 amplifications across sex, race, and cancer types studied to guide HER2 therapies ( Dr Marc Machaalani - Dana-Farber Cancer Institute, Boston, USA )

Trastuzumab deruxtecan effective against brain metastases in HER2-positive...

Dr Nancy Lin - Dana-Farber Cancer Institute, Boston, USA

Trastuzumab deruxtecan effective against brain metastases in HER2-positive breast cancer ( Dr Nancy Lin - Dana-Farber Cancer Institute, Boston, USA )

Patient reported outcomes for telisotuzumab vedotin in c-Met protein...

Prof Nicolas Girard - Institut Curie, Paris, France

Patient reported outcomes for telisotuzumab vedotin in c-Met protein overexpressing EGFR WT nonsquamous NSCLC ( Prof Nicolas Girard - Institut Curie, Paris, France )

More from ecancer